From: Medication-induced osteonecrosis of the jaw: a review of cases from the Food and Drug Administration Adverse Event Reporting System (FAERS)
Medication
Reporting Odds Ratio (ROR)
1. Denosumab
129.3
2. Zoledronic Acid
380.9
3. Alendronate
80.2
4. Ibandronate
45.0
5. Lenalidomide
1.8
6. Pamidronate
255.7
7. Bevacizumab
6.2
8. Prednisolone
5.3
9. Risedronate
52.3
10. Dexamethasone
3.9